Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RAPCX | 10.88 | 0.05 | +0.46% |
| Cohen & Steers Real Assets C | |||
| LAMHX | 23.81 | -0.26 | -1.08% |
| Lord Abbett Dividend Growth R6 | |||
| RISAX | 26.58 | -0.31 | -1.15% |
| Manning & Napier Rainier Intl Discv S | |||
| NSOPX | 16.39 | -0.19 | -1.15% |
| North Star Opportunity A | |||
| RGAAX | 68.39 | -0.83 | -1.20% |
| American Funds Growth Fund of Amer R1 | |||
A.I.dvisor indicates that over the last year, ARGNF has been loosely correlated with ARGX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGNF jumps, then ARGX could also see price increases.
| Ticker / NAME | Correlation To ARGNF | 1D Price Change % | ||
|---|---|---|---|---|
| ARGNF | 100% | N/A | ||
| ARGX - ARGNF | 54% Loosely correlated | -1.51% | ||
| BLUE - ARGNF | 45% Loosely correlated | N/A | ||
| MNKD - ARGNF | 30% Poorly correlated | -3.13% | ||
| TNXP - ARGNF | 25% Poorly correlated | -7.41% | ||
| ROIV - ARGNF | 24% Poorly correlated | -1.31% | ||
More | ||||